Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ASNS | US
-0.07
-4.83%
Healthcare
Biotechnology
30/06/2024
21/10/2024
1.38
1.45
1.45
1.37
Actelis Networks Inc. engages in the design development manufacture and marketing of cyber hardened hybrid fiber copper networking solutions for Internet of Things and telecommunication companies in North America Europe the Middle East Africa Latin America and the Asia Pacific. It provides cyber-hardened rapid-deployment networking solutions for wide-area IoT applications including federal state and local governments; intelligent traffic systems; and military utility rail telecom and campus applications. The company's products include ethernet access switches; network aggregator switches; industrial managed ethernet switches and extenders; ethernet first mile repeaters; broadband amplifiers; and Advanced MetaLIGHT element management systems software which enables remote management monitoring maintenance and configuration of the installed equipment in the network. It serves offers its products through system integrators distributors contractors resellers and consultants. The company was incorporated in 1998 and is headquartered in Fremont California.
View LessStrong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
64.1%1 month
64.2%3 months
87.0%6 months
997.2%-
-
7.67
2.52
0.28
-0.66
1.44
-
-5.73M
8.30M
8.30M
-
-2.83
-
81.00
-437.82
0.27
6.41
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.20
Range1M
0.34
Range3M
0.71
Rel. volume
0.32
Price X volume
152.08K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Plus Therapeutics Inc | PSTV | Biotechnology | 1.4 | 8.25M | -2.78% | n/a | -45.04% |
Soligenix Inc | SNGX | Biotechnology | 3.59 | 8.19M | -7.12% | n/a | 84.28% |
TFFP | TFFP | Biotechnology | 2.3 | 7.97M | 11.11% | n/a | 1.26% |
Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.73 | 7.74M | 3.28% | n/a | 0.00% |
Moleculin Biotech Inc | MBRX | Biotechnology | 2.67 | 7.59M | 3.29% | n/a | 3.00% |
Pulmatrix Inc | PULM | Biotechnology | 2.04 | 7.45M | 0.97% | n/a | 0.18% |
Cyclerion Therapeutics Inc | CYCN | Biotechnology | 2.9099 | 7.32M | 16.40% | n/a | 0.00% |
Orgenesis Inc | ORGS | Biotechnology | 1.53 | 7.30M | -27.49% | n/a | -84.02% |
Virax Biolabs Group Limited Ordinary Shares | VRAX | Biotechnology | 1.63 | 7.08M | 6.54% | n/a | 4.18% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.49 | 7.07M | 2.75% | n/a | 0.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.66 | 0.53 | Cheaper |
Ent. to Revenue | 1.44 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 7.67 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 87.00 | 72.80 | Par |
Debt to Equity | 2.52 | -1.23 | Expensive |
Debt to Assets | 0.28 | 0.25 | Par |
Market Cap | 8.30M | 3.66B | Emerging |